1 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Next-Generation Antibody-Drug Conjugates for safer and more effective cancer therapies (ADC)
Date du début: 1 mai 2016, Date de fin: 30 sept. 2016,
Oncolinx has developed a novel molecular platform allowing for non-invasive and highly effective cancer cures. The platform carries a killing drug (Azonafide), linked to an antibody, specifically targeting and destroying only malignant tumour cells. These molecular complexes are called Antibody Drug Conjugates (ADCs) and represent a strong, valid alternative to current chemotherapies. Oncolinx’s i ...
Voir le projet